A Luxembourg-based private equity firm tried to spend $1.65 billion (enough to pay for a year of college tuition for over 55,000 students) to become the only place you could take your dog for cancer treatment in Richmond, Virginia.

The Non-Financial Ledger

What the merger documents never put a price on.

When Your Pet Is Dying, They Know You’ll Pay Anything

Emergency and specialty veterinary care occupies one of the most emotionally raw spaces in consumer life. A pet owner arriving at an emergency clinic with an animal in crisis has no leverage whatsoever. They cannot comparison-shop. They cannot wait. They cannot walk away. The relationship between a pet owner in that moment and the clinic holding the only neurologist or oncologist in their city is one of pure, unfiltered dependency.

The FTC’s complaint makes clear that this dynamic is exactly what makes geographic monopoly in specialty vet care so dangerous. When Compassion-First/NVA and Ethos exist as two competing providers in a city, each one actively monitors the other’s pricing and lowers their fees to attract more referrals from general practitioners. The moment one of them disappears, that price discipline vanishes entirely. The remaining company faces no competitive pressure to keep costs down, and the customer facing a $6,000 oncology bill for their dog has nowhere else to go.

This is the human cost the balance sheet does not capture: the cancer diagnosis that comes back during a recession, the specialist appointment that gets delayed because the wait list tripled after a competitor closed, the family that euthanizes a treatable animal because the price quote from the only clinic in the city is simply out of reach. These outcomes do not appear in merger valuation models. They appear in the grief of real families.

Dignity Has a Geography

The FTC’s complaint identifies four specific local markets: Richmond, Virginia; the Washington D.C. metro area; Denver, Colorado; and San Francisco, California. These are not abstractions. These are the cities where specific families take their pets to specific specialists, and where competition between Compassion-First/NVA and Ethos was actively holding prices in check at the time the deal was announced.

In Richmond, the deal was not simply a market concentration event. It was a merger to monopoly. Two providers of veterinary cancer care would have become one, with no meaningful alternative for any family within a reasonable driving distance. The FTC explicitly used the phrase “merger to monopoly” to describe what would have happened in that market. That language means something: it means that after the deal, the corporation could charge whatever it wanted, offer whatever quality of care it chose, and families would have no recourse except to leave the city or accept the terms.

Pet ownership is not a luxury exclusive to the wealthy, despite what the price of specialty vet care sometimes suggests. Millions of working-class and middle-income families share their homes with animals they love. The emotional bond is identical regardless of income. The ability to afford care when that animal is suffering is where economic inequality intersects with grief in the most direct and painful way possible. A monopoly in specialty veterinary care does not just raise prices; it decides who gets to save their animal and who does not.

Legal Receipts

These are direct statements from the FTC’s formal complaint, filed June 28, 2022. Read them in the corporations’ own words.

“Respondent Compassion-First/NVA itself has grown principally through large acquisitions that were reported to federal antitrust authorities pursuant to the Hart-Scott-Rodino Act. First, in 2020, Compassion-First expanded through its acquisition of NVA, which it combined with Compassion-First to form Compassion-First/NVA. Through this acquisition, Compassion-First acquired 33 emergency and specialty clinics located throughout the United States.” FTC Complaint, Section IV, Paragraph 10 — describing the corporation’s acquisition-as-growth strategy

“There has been a growing trend towards consolidation in the emergency and specialty veterinary services markets across the United States in recent years by large chains including Respondent Compassion-First/NVA.” FTC Complaint, Section IV, Paragraph 10 — on the industry-wide consolidation pattern

“Specialists and emergency veterinarians often monitor procedure prices charged by competing specialty and emergency clinics and lower their prices to attract more referrals. Indeed, internal business documents from Compassion-First/NVA explain that Respondent’s pricing policy is to [REDACTED – Redacted in Public Version of Source Document].” FTC Complaint, Section VI, Paragraph 21 — on competitive price discipline and what happens when it ends

“Few Americans are able to obtain insurance for emergency and specialty veterinary services, however, as such insurance is not widely available. As a result, the price effects that would result from the Acquisition would be born as out-of-pocket costs directly by American consumers.” FTC Complaint, Section VI, Paragraph 22 — on who ultimately pays for monopoly pricing

“Entry into the relevant markets would not be timely, likely, or sufficient in magnitude, character, and scope to deter or counteract the anticompetitive effects of the Acquisition. For de novo entrants, obtaining financing to build a new specialty or emergency veterinary facility and acquiring or leasing necessary equipment can be expensive and time consuming… Consequently, specialists are frequently in short supply, and recruiting them to move to a new area often takes more than two years.” FTC Complaint, Section V, Paragraph 19 — on why no new competitor could realistically fill the gap

Societal Impact Mapping

Economic Inequality: The Out-of-Pocket Trap

The FTC’s complaint lands a damning fact directly: few Americans carry insurance for emergency or specialty veterinary services because it is simply not widely available. This matters enormously in the context of this deal. When a monopoly raises prices in a market where insurance does not cushion the blow, every dollar of that increase comes directly out of the pockets of individual families, usually at the exact moment when they are least prepared to absorb it.

The FTC explicitly states that “the price effects that would result from the Acquisition would be born as out-of-pocket costs directly by American consumers.” This is the antitrust complaint describing, in the dry language of regulatory filings, a scenario where a private equity firm in Luxembourg raises the price of saving your cat’s life and you have no safety net. The family with money gets the oncologist. The family without it faces a different conversation.

The complaint also makes clear that specialists actively compete on price today, specifically to win referrals from general practice veterinarians. That competitive pressure is the only thing keeping specialty and emergency vet costs from being set arbitrarily. Eliminate the competition, and that price anchor disappears. The FTC’s own language anticipates that the merged entity “would have a significantly reduced incentive to compete” not just on price but on quality, appointment flexibility, communication with referring vets, and adoption of new treatments and equipment.

Public Health: When Specialist Scarcity Becomes a Crisis

The FTC’s complaint explains in detail why the specialty veterinary market is especially difficult to enter or recover once competition is eliminated. Becoming a board-certified veterinary specialist requires extensive education and training beyond a general veterinary degree. Specialists in neurology, oncology, cardiology, and critical care are already “frequently in short supply” even before any merger, according to the FTC. This is a market where the supply of qualified professionals is structurally constrained regardless of price signals.

When a monopoly forms in a market with a structural specialist shortage, the degradation in public health outcomes is not theoretical. It is mechanical. Longer wait times for oncology consultations, reduced appointment flexibility, less investment in new equipment and training for referring general practitioners — the FTC explicitly lists all of these as non-price competitive dimensions that the merged entity would have “a significantly reduced incentive” to maintain. These are not minor inconveniences. For an animal with a fast-moving cancer or a neurological emergency, delays in care translate directly into deterioration and death.

Emergency veterinary staffing faces the same structural barrier. The complaint notes that building and staffing an emergency clinic “can be expensive and time consuming” and that maintaining emergency personnel and equipment creates ongoing costs and risks that make new entry unattractive. A monopoly emergency clinic that knows no competitor can realistically enter the market within two years faces zero accountability for the quality or availability of its care.

The “Cost of a Life” Metric

What Now?

The FTC blocked this specific deal. The consolidation trend it was part of has not stopped.

Corporate Roles at the Center of This Deal

Regulatory Watchlist

• Federal Trade Commission (FTC): Filed the complaint that stopped this deal. The FTC’s prior notice and prior approval provisions on earlier JAB acquisitions directly prevented at least one additional anticompetitive acquisition from proceeding.
• Department of Justice, Antitrust Division: Joint federal antitrust enforcement partner on merger review under Hart-Scott-Rodino Act filings.
• State Attorneys General: State-level antitrust enforcement can challenge local market monopolies independently of federal action.

What You Can Actually Do

The FTC won this round, but JAB still controls dozens of specialty and emergency veterinary clinics across the United States. Private equity consolidation in veterinary care is an ongoing extraction project. Your general practice veterinarian likely refers patients to a corporate-owned specialty clinic and may not know who ultimately owns it. Ask. Community-owned veterinary cooperatives and nonprofit veterinary schools offer genuine alternatives in some cities; find them and support them with your dollars and your referrals. Mutual aid networks that help low-income families afford veterinary care exist in most major cities; volunteer and donate to keep them funded. When the FTC opens public comment periods on veterinary or healthcare mergers, submit a comment. Regulatory agencies pay attention to volume. Your voice in a comment docket is one of the cheapest and most direct forms of corporate accountability available to an ordinary person.